InvestorsHub Logo
icon url

battyman

08/23/13 5:51 PM

#52905 RE: HSmith #52899

I'm not sure that the Macular partnership in and of itself is going to be huge for Fuse, but if Macular's formula slows the progression of Macular Degeneration by 17% and if Fuse's oral drop technology increases the speed and efficacy of Macular's formula, then it can't be anything but good for Fuse. Some will view it as a proof of concept and realize that there are a multitude of other products that could be improved by such a delivery formula.